Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interrupters of VAscular daMAge in Malignant Hypertension: Role of Inflammasome, Angiogenic and Vasoactive System

NCT04991077 is registered in ClinicalTrials.gov with Centre Hospitalier de PAU as lead sponsor.

NCT NCT04991077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04991077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interrupters of VAscular daMAge in Malignant Hypertension: Role of Inflammasome, Angiogenic and Vasoactive System
Lead sponsor
Centre Hospitalier de PAU
Phase
Observational
Overall status
Completed
Start date
February 7, 2022
Completion date
October 11, 2024
Enrollment
45 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignant hypertension